Interval-Censored Time-to-Event Data Interval-Censored Time-to-Event Data
Chapman & Hall/CRC Biostatistics Series

Interval-Censored Time-to-Event Data

Methods and Applications

Ding-Geng (Din) Chen and Others
    • $67.99
    • $67.99

Publisher Description

Interval-Censored Time-to-Event Data: Methods and Applications collects the most recent techniques, models, and computational tools for interval-censored time-to-event data. Top biostatisticians from academia, biopharmaceutical industries, and government agencies discuss how these advances are impacting clinical trials and biomedical research.Divid

GENRE
Science & Nature
RELEASED
2012
July 19
LANGUAGE
EN
English
LENGTH
434
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
3.3
MB

More Books by Ding-Geng (Din) Chen, Jianguo Sun & Karl E. Peace

Applied Meta-Analysis with R and Stata Applied Meta-Analysis with R and Stata
Applied Meta-Analysis with R and Stata
2021
Statistical Causal Inferences and Their Applications in Public Health Research Statistical Causal Inferences and Their Applications in Public Health Research
Statistical Causal Inferences and Their Applications in Public Health Research
2016
Advanced Statistical Analytics for Health Data Science with SAS and R Advanced Statistical Analytics for Health Data Science with SAS and R
Advanced Statistical Analytics for Health Data Science with SAS and R
2025
Clinical Trial Methodology Clinical Trial Methodology
Clinical Trial Methodology
2010
Clinical Trial Biostatistics and Biopharmaceutical Applications Clinical Trial Biostatistics and Biopharmaceutical Applications
Clinical Trial Biostatistics and Biopharmaceutical Applications
2014
Modern Biostatistical Methods for Evidence-Based Global Health Research Modern Biostatistical Methods for Evidence-Based Global Health Research
Modern Biostatistical Methods for Evidence-Based Global Health Research
2022

Other Books in This Series

Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
Real-World Evidence in Drug Development and Evaluation
2021
Medical Risk Prediction Models Medical Risk Prediction Models
Medical Risk Prediction Models
2021
Biomarker Analysis in Clinical Trials with R Biomarker Analysis in Clinical Trials with R
Biomarker Analysis in Clinical Trials with R
2020
Biosimilar Clinical Development: Scientific Considerations and New Methodologies Biosimilar Clinical Development: Scientific Considerations and New Methodologies
Biosimilar Clinical Development: Scientific Considerations and New Methodologies
2016
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
Innovative Methods for Rare Disease Drug Development
2020
Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
Statistical Design, Monitoring, and Analysis of Clinical Trials
2021